Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytogenetics and oncogenes in leukemia.

M R Baer1, C D Bloomfield

  • 1Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263.

Current Opinion in Oncology
|February 1, 1992
PubMed
Summary

Cytogenetic and molecular studies are crucial for leukemia prognosis and personalized treatment. Advanced techniques help quantify leukemia cells, guiding targeted therapies against specific gene abnormalities.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis.

Leukemia·2019
Same author

Phase 2 study of gandotinib (LY2784544) in patients with myeloproliferative neoplasms.

Leukemia research·2018
Same author

No evidence for microsatellite instability in acute myeloid leukemia.

Leukemia·2017
Same author

The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia.

Leukemia·2017
Same author

Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide.

Leukemia·2017
Same author

Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemia.

Leukemia·2016

Area of Science:

  • Hematology
  • Oncology
  • Genetics

Background:

  • Cytogenetic and molecular studies are increasingly vital in leukemia patient management.
  • Established cytogenetic findings serve as key prognostic indicators in acute leukemias.

Purpose of the Study:

  • To highlight the growing significance of cytogenetic and molecular diagnostics in leukemia.
  • To underscore the role of genetic alterations in leukemogenesis.
  • To discuss the application of advanced techniques for monitoring treatment response.

Main Methods:

  • Utilizing cytogenetic analysis to identify chromosomal abnormalities.
  • Employing molecular techniques, including polymerase chain reaction and in situ hybridization.
  • Analyzing gene structure and expression alterations in leukemic cells.

Main Results:

  • Cytogenetic findings are established independent prognostic indicators in acute leukemias.
  • Significant advancements in understanding genes involved in leukemogenesis.
  • New techniques enable quantification of residual leukemia cells post-therapy.

Conclusions:

  • Cytogenetic and molecular data facilitate individualized leukemia treatment strategies.
  • Therapies can be specifically targeted towards leukemia-specific abnormal gene products.
  • These advancements promise more effective and personalized leukemia care.

Related Experiment Videos